Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Scott Braunstein currently holds 4,956 shares of Esperion Therapeutics, Inc. (ESPR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott Braunstein has been a net buyer of ESPR stock. They have purchased $242.8K and sold $226.3K worth of shares.
Scott Braunstein's most recent insider trade was on Mar 3, 2026, when they sold 25,000 shares at $0.00 per share.
Scott Braunstein serves as Executive at Esperion Therapeutics, Inc. (ESPR). They have executed 27 insider transactions totaling $469.1K over their tenure at the company.
Scott Braunstein holds the position of Executive at Esperion Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Scott Braunstein has shown a buying trading pattern, with $242.8K in total purchases and $226.3K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Scott Braunstein was on Mar 27, 2024, when they sold $214.0K worth of MRNS shares. This transaction involved 50,000 shares at $4.28 per share.
Scott Braunstein currently owns 4,956 shares of Esperion Therapeutics, Inc. (ESPR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Scott Braunstein's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Scott Braunstein has 27 Form 4 filings on record as an insider at Esperion Therapeutics, Inc..
Set alerts for Scott Braunstein and 40,000+ other insiders.